Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
3.
N Engl J Med ; 390(6): e12, 2024 Feb 08.
Article in English | MEDLINE | ID: mdl-38324481
4.
N Engl J Med ; 390(8): e18, 2024 Feb 22.
Article in English | MEDLINE | ID: mdl-38381671
5.
N Engl J Med ; 389(22): e47, 2023 Nov 30.
Article in English | MEDLINE | ID: mdl-38048187
7.
JAMA Netw Open ; 5(10): e2238513, 2022 10 03.
Article in English | MEDLINE | ID: mdl-36282498

ABSTRACT

Importance: Menstrual cycle characteristics may be associated with an increased risk of cardiovascular disease (CVD). However, existing studies are limited, and few have explored the mediating role of established CVD risk factors. Objective: To explore the associations of menstrual cycle characteristics across the reproductive lifespan with the risk of CVD and to what extent these associations were mediated by hypercholesterolemia, chronic hypertension, and type 2 diabetes. Design, Setting, and Participants: This cohort study prospectively followed Nurses' Health Study II participants between 1993 and 2017 who reported menstrual cycle regularity and length for ages 14 to 17 years and 18 to 22 years at enrollment in 1989 and updated current cycle characteristics in 1993 (at ages 29 to 46 years). Data analysis was performed from October 1, 2019, to January 1, 2022. Exposures: Menstrual cycle regularity and length across the reproductive lifespan. Main Outcomes and Measures: Incident CVD events of interest, including fatal and nonfatal coronary heart disease (CHD; myocardial infarction [MI] or coronary revascularization) and stroke. Results: A total of 80 630 Nurses' Health Study II participants were included in the analysis, with a mean (SD) age of 37.7 (4.6) years and body mass index of 25.1 (5.6) at baseline. Over 24 years of prospective follow-up, 1816 women developed their first CVD event. Multivariable Cox proportional hazards models showed that, compared with women reporting very regular cycles at the same ages, women who had irregular cycles or no periods at ages 14 to 17, 18 to 22, or 29 to 46 years had hazard ratios for CVD of 1.15 (95% CI, 0.99-1.34), 1.36 (95% CI, 1.06-1.75), and 1.40 (95% CI, 1.14-1.71), respectively. Similarly, compared with women reporting a cycle length of 26 to 31 days, women reporting a cycle length 40 days or more or a cycle too irregular to estimate from ages 18 to 22 or 29 to 46 years had hazard ratios for CVD of 1.44 (95% CI, 1.13-1.84) and 1.30 (95% CI, 1.09-1.57), respectively. Mediation analyses showed that subsequent development of hypercholesteremia, chronic hypertension, and type 2 diabetes only explained 5.4% to 13.5% of the observed associations. Conclusions and Relevance: In this cohort study, both irregular and long menstrual cycles were associated with increased rates of CVD, which persisted even after accounting for subsequently established CVD risk factors.


Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Hypercholesterolemia , Hypertension , Female , Humans , Adult , Middle Aged , Adolescent , Young Adult , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cohort Studies , Risk Factors , Prospective Studies , Diabetes Mellitus, Type 2/complications , Longevity , Menstrual Cycle , Hypertension/epidemiology , Hypertension/complications
9.
NEJM Evid ; 1(7): EVIDe2200139, 2022 Jul.
Article in English | MEDLINE | ID: mdl-38319263

ABSTRACT

Fossil-Fuel Pollution and Climate ChangeThe editors announce a new NEJM Group series on climate change and the increasingly urgent health and care delivery challenges we face. Articles will appear in the New England Journal of Medicine, in NEJM Evidence, and in NEJM Catalyst Innovations in Care Delivery.

12.
13.
N Engl J Med ; 381(8): 773-774, 2019 08 22.
Article in English | MEDLINE | ID: mdl-31433926
15.
N Engl J Med ; 377(7): 690-691, 2017 08 17.
Article in English | MEDLINE | ID: mdl-28813213
16.
N Engl J Med ; 376(26): 2591-2592, 2017 06 29.
Article in English | MEDLINE | ID: mdl-28657876
19.
Matern Child Health J ; 20(9): 1804-13, 2016 09.
Article in English | MEDLINE | ID: mdl-27003150

ABSTRACT

Objectives To prospectively evaluate the association between gestational weight gain (GWG), prepregnancy body mass index (BMI), and hypertensive disorders of pregnancy using the revised Institute of Medicine (IOM) Guidelines. Methods We examined these associations among 1359 participants in Proyecto Buena Salud, a prospective cohort study conducted from 2006 to 2011 among women from the Caribbean Islands. Information on prepregnancy BMI, GWG, and incident diagnoses of hypertension in pregnancy were based on medical record abstraction. Results Four percent (n = 54) of women were diagnosed with hypertension in pregnancy, including 2.6 % (n = 36) with preeclampsia. As compared to women who gained within IOM GWG guidelines (22.8 %), those who gained above guidelines (52.5 %) had an odds ratio of 3.82 for hypertensive disorders (95 % CI 1.46-10.00; ptrend = 0.003) and an odds ratio of 2.94 for preeclampsia (95 % CI 1.00-8.71, ptrend = 0.03) after adjusting for important risk factors. Each one standard deviation (0.45 lbs/week) increase in rate of GWG was associated with a 1.74 odds of total hypertensive disorders (95 % CI 1.34-2.27) and 1.86 odds of preeclampsia (95 % CI 1.37-2.52). Conclusions for Practice Findings from this prospective study suggest that excessive GWG is associated with hypertension in pregnancy and could be a potentially modifiable risk factor in this high-risk ethnic group.


Subject(s)
Hispanic or Latino/statistics & numerical data , Hypertension, Pregnancy-Induced/ethnology , Hypertension/ethnology , Obesity/complications , Weight Gain , Adolescent , Adult , Body Mass Index , Female , Humans , Hypertension/etiology , Pre-Eclampsia/epidemiology , Pregnancy , Prospective Studies , Puerto Rico/epidemiology , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL